Quinton Oswald
Retired CEO and Vero Beach Resident Quinton Oswald
From 2016 through the end of 2018, experienced executive Quinton Oswald led Manssas, Virginia’s Notal Vision in the role of chief executive officer. During his time with the early commercial stage company, Quinton Oswald played a key role in planning the expansion expanding the Natal Vision patient based diagnostic and monitoring platform from a nine region market test to a national launch. Additional responsibilities at the company ranged from building a breakthrough home based OCT system to manage the entire patient journey through Dry and We AMD to raising capital for a successful IPO or an alternative company exit. His executive career concluded in 2018 , though he continued as a board member to guide the company’s new chief executive officer while residing Vero Beach, Florida.
Prior to his time at Notal Vision, Mr. Oswald was president and chief executive officer of Neurotech in Cumberland, Rhode Island. He gained additional executive experience as chief executive officer of SARcode Corporation in San Francisco where he successfully raised capital and sold the company to Shire .Before elating his first start-up he was the Business Unit Head and VP at Genentech where he lead the launch of Lucentis ,the first effective treatment for Wet AMD .He also had senior roles at Novartis and Bristol Myers Squibb where his last role was as president of Latin America and Canada with Worldwide Medicines Group. His interests in retirement, meanwhile, range from traveling internationally to playing golf throughout the Vero Beach region.
Other Media
Contact
Vero Beach, FL US